A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content
- PMID: 12552126
- PMCID: PMC298755
- DOI: 10.1073/pnas.0336724100
A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content
Abstract
To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/298755/bin/pq0336724001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/298755/bin/pq0336724002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/298755/bin/pq0336724003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/298755/bin/pq0336724004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/298755/bin/pq0336724005.gif)
Similar articles
-
Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.Circulation. 2010 Jan 26;121(3):426-35. doi: 10.1161/CIRCULATIONAHA.109.888735. Epub 2010 Jan 11. Circulation. 2010. PMID: 20065164 Free PMC article.
-
CD36 deficiency rescues lipotoxic cardiomyopathy.Circ Res. 2007 Apr 27;100(8):1208-17. doi: 10.1161/01.RES.0000264104.25265.b6. Epub 2007 Mar 15. Circ Res. 2007. PMID: 17363697
-
The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart.Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):391-6. doi: 10.1097/01.mco.0000134371.70815.32. Curr Opin Clin Nutr Metab Care. 2004. PMID: 15192440 Review.
-
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.J Clin Invest. 2002 Jan;109(1):121-30. doi: 10.1172/JCI14080. J Clin Invest. 2002. PMID: 11781357 Free PMC article.
-
PPAR signaling in the control of cardiac energy metabolism.Trends Cardiovasc Med. 2000 Aug;10(6):238-45. doi: 10.1016/s1050-1738(00)00077-3. Trends Cardiovasc Med. 2000. PMID: 11282301 Review.
Cited by
-
New insights into the roles of olfactory receptors in cardiovascular disease.Mol Cell Biochem. 2024 May 18. doi: 10.1007/s11010-024-05024-x. Online ahead of print. Mol Cell Biochem. 2024. PMID: 38761351 Review.
-
Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy.Front Cardiovasc Med. 2024 Mar 25;11:1375400. doi: 10.3389/fcvm.2024.1375400. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38596692 Free PMC article. Review.
-
Lipidomics Reveals Myocardial Lipid Composition in a Murine Model of Insulin Resistance Induced by a High-Fat Diet.Int J Mol Sci. 2024 Feb 26;25(5):2702. doi: 10.3390/ijms25052702. Int J Mol Sci. 2024. PMID: 38473949 Free PMC article.
-
Role of lipins in cardiovascular diseases.Lipids Health Dis. 2023 Nov 14;22(1):196. doi: 10.1186/s12944-023-01961-6. Lipids Health Dis. 2023. PMID: 37964368 Free PMC article. Review.
-
Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?ESC Heart Fail. 2023 Oct;10(5):3114-3122. doi: 10.1002/ehf2.14449. Epub 2023 Aug 23. ESC Heart Fail. 2023. PMID: 37614055 Free PMC article.
References
-
- Rubler S, Dlugash J, Yuceoglu Y Z, Kumral T, Branwood A W, Grishman A. Am J Cardiol. 1972;30:595–602. - PubMed
-
- Stone P H, Muller J E, Hartwell T, York B J, Rutherford J D, Parker C B, Turi Z G, Strauss H W, Willerson J T, Robertson T. J Am Coll Cardiol. 1989;14:49–57. - PubMed
-
- Neely J R, Rovetto M J, Oram J F. Prog Cardiovasc Dis. 1972;15:289–329. - PubMed
-
- Lopaschuk G D, Spafford M. Circ Res. 1989;65:378–387. - PubMed
-
- Belke D D, Larsen T S, Gibbs E M, Severson D L. Am J Physiol. 2000;279:E1104–E1113. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials